VEGFA has been discussed as a potential target for treating PD40 and a recent study suggests blocking of VEGFA to prevent blood–brain-barrier disruption, which has been implicated in several neurodegenerative diseases, including PD41. This evidence concerns the gene VEGFA and neurodegenerative disease.